Screening of the Biologoical Activity from Water Extracts of the Medicinal Plants and the Protective Effect of R. palmatum on MTPT-induced Neurotoxicity |
Kim Tae Eun
(Department of Physiology, College of Oriental Medicine, Sangji University)
Yoon Yeo Min (Department of Physiology, College of Oriental Medicine, Sangji University) Park Yong In (Department of Physiology, College of Oriental Medicine, Sangji University) Kim Youn Seok (Department of Rehabilitation, Joong Hwa Oriental Medical Hospital) Jeon Byung Hun (Department of Pathology, College of Oriental medicine, Wonkwang University) Kim Myung Dong (Department of Physiology, College of Oriental Medicine, Sangji University) |
1 |
Role of free radicals and catalytic metal ions in human disease: an overview
/
|
2 |
Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridinium, a metabolite of the neurotoxine, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
/
|
3 |
1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine is neurotoxic to the nigro-striatal dopamine pathway
/
|
4 |
/
|
5 |
Oat antioxidants
/
|
6 |
Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity by 1-methyl-4-phenylpyridinium ion
/
|
7 |
Selective accumulation of MPP+ in the substantia nigra: a key to neurotoxicity
/
|
8 |
Resistance of golden hamster to 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine: relationship with low levels of regional monoamine oxidase-B
/
|
9 |
Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases
/
|
10 |
Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridinium ion
/
|
11 |
Toxins and Parkinson's disease: MPTP parkinsonism in humans and animals
/
|
12 |
Protection against the dopaminergic neurotoxicity of 1- methyl- 4- phenyl- 1,2,5,6 -tetrahydropyridine by monoamine oxidase inhibitor
/
|
13 |
Oxidation products arising from the action of monoamine oxidase B on 1-methyl-4-benzyl-1,2,3,6-tetrahydropyridine, A nonneurotoxic analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
/
|
14 |
The specific vulmerability of the substantia nigra to MPTP is related to the presence of transition metals
/
|
15 |
Apomorphine protects against MPTP-induced neurotoxicity in mice
/
|
16 |
Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys
/
|
17 |
Selegiline is neuroprotective in primary brain cultures treated with 1-methyl-4-phenylpyridinium
/
|
18 |
(-)-deprenyl of 1-methyl-4-phenylpyridinium ion (MPP+) -induced apotosis independent of MAO-B inhibition
/
|
19 |
The effects of L-deprenyl treatment, alone and combined with GM1 ganglioside, on striatal dopamine content and substantia nigra pars compacta neurons
/
|
20 |
7-Nitroindazole prevents 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine induced ATP loss in the mouse striatum
/
|
21 |
MAO-B inhibitors: multiple roles in the therapy of neurodegenerative disorders?
/
|
22 |
The protective of riluzole in the MPTP model of Parkinson's disease in mice is not due to in MPP+ accumulation
/
|
23 |
Brief communication azulenyl nitrone spin trap protect against MPTP neurotoxicity
/
|
24 |
Biological effects of the superoxide radical
/
|
25 |
Historical introduction to free radical and antioxidant biomedical research
/
|
26 |
Oxidative processes and antioxidative defense mechanism in the aging brain
/
|
27 |
Involvement of monoamine oxidase inhibition in neuroprotective and neurorestorative effects of Ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C57 mice
/
|
28 |
Neuroprotection by sodium salicylate against 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity
/
|
29 |
Monoamine oxidase_B inhibitors in treatment Alzheimers disease
/
|
30 |
Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine in C57BL/6 mice
/
|
31 |
Elevation of antioxidant potency in the brain of mice by low-dose <TEX>$\gamma$</TEX>-ray irradiation and its effect on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)- induced brain damage
/
ScienceOn |
32 |
/
|
33 |
/
|
34 |
/
|
35 |
/
|
36 |
Serum lipoperoxide levels in patients suffering from liver disease
/
|
37 |
/
|
38 |
/
|
39 |
Total antioxidant status in plasma and body fluids
/
|
40 |
Correlation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity with blood brain barrier monoamine oxidase activity
/
|
41 |
A new and rapid colorimetric determination acetylcholinesterase activity
/
|
42 |
The contribution of plant food antioxidants to human health
/
|
43 |
三和散이 腦組織의 acetylcholine esterase 및 monoamine oxidase 活性에 미치는 影響
/
|
44 |
七福飮이 노화 백서 뇌조직의 생화학적 변화에 미치는 영향
/
|
45 |
定志丸이 腦組織의 生化學的 變化와 神經細胞의 損傷에 미치는 實驗的 硏究
/
|
46 |
Monoamine oxidase activity and monoamine metabolism in brains of Parkinsonianpatients treated with L-deprenyl
/
|
47 |
Relationship of resistance to oxygen free radicals to CuZn-superoxide dismutase activity in trasgenic, transfected, and trisomic cells
/
|
48 |
Protein measurment with the Folin-phenol reagent
/
|
49 |
Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and glutathione system
/
|
50 |
Are reative oxygen species involved in Alzheimer's disease?
/
|
51 |
Screening of the acetylcholinesterase inhibitors from medicinal plants
/
|
52 |
Kinetic evaluation of MAO-B activity following oral administration of selegiline and desmethyl-selegiline in the rat
/
|
53 |
Pargyline-induced mania in primary affective disorder: case report
/
|
54 |
Comparative antioxidant potential of anaethetics and perioperative drugs in vitro
/
|
55 |
Shortcomings of an automated assay for total antioxidant status in biological fluids
/
|
56 |
Analytical aspects of antioxidants and free radical activity in clinical biochemistry
/
|
57 |
Is measuring serum antioxidant capacity clinically useful?
/
|
58 |
Comparison of relative antioxidant activities of British medicinal plant species in vitro
/
|
59 |
Hydroxyl radical scavenging activity of flavonoids
/
|
60 |
Age- related changes in reactive oxygen species production in rat brain homogenates
/
|
61 |
Effective human cancer prevention as goal for the regulation of environmental chemicals
/
|
62 |
No changes in behavior, nigro-striatal system neurochemistry or neuronal cell death following toxic multiple oral paraquat administration to rats
/
|
63 |
Effects of nicotine on hydroxyl free radical formation in vitro and on MPTP-induced neurotoxicity in vivo
/
|
64 |
Mechanism of food restriction: Protection of cellular homeostasis
/
|
65 |
MPTP produces differential oxidative stress and antioxidative responses in the nigrostriatal and mesolimbic dopaminergic pathways
/
|
66 |
1-methyl-4-phenylpyridinium (MPP+) analogs: in vivo neurotoxicity and inhibition of striatal synaptosomal dopamine uptake
/
|
67 |
/
|
68 |
The neurotoxicity and the relevance to Parkonson's disease
/
|
69 |
Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4- phenyl-1,2,3,6- tetrahydropyridinyl derivatives
/
|
70 |
/
|
71 |
The concurrent estimation of the major monoamine metabolites in human and non-human primate brain by HPLC with fluorescence and electrochemical detection
/
|
72 |
Quinoline and quinaldine as naturally occurring inhibitors specific for type A monoamine oxidase
/
|
73 |
Screening of unsubstituted cyclic compounds as inhibitors of monoamine oxidases
/
|
74 |
Isolation of monoamine oxidase B inhibitory compound from the leaves of Eucommia ulmoides
/
|
75 |
Phenolics with inhibitory activity on mouse brain monoamine oxidase (MAO) from whole parts of Artemisia vulgaris L (Mugwort)
/
|
76 |
Difference in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/BL and CD-1 mice
/
|
77 |
Spontaneaus blink rates correlate with dopamine levels in the caudate nucleus of MPTP-treated monkeys
/
|
78 |
Comparative toxicity of MPTP, MPP+ and 3,3- dimethyl-MPDP+ to dopaminergic neurons of the rat substantia nigra
/
|
79 |
MK-81 fail to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridium in rats
/
|
80 |
Prevalence of Alzheimer' disease in community population of older persons
/
|
81 |
/
|
82 |
Diagnosis of Alzheimer's disease
/
|
83 |
Toxicology and biochemistry of butylated hydroxyanisole and butylated hydroxytoluene
/
|
84 |
NADPH-dependent and O2-dependent lipid-peroxidation
/
|
85 |
A simple screening method for antioxidants and isolation of several antioxidants produced by marine bacteria from fish and shellfish
/
|
86 |
Oxidative stress and genetics in the pathogenesis of Parkinsons disease
/
|
87 |
Phenolic antioxidants: health protection branch studies on butylated hydroxyanisole
/
|
88 |
Evidence fro neuronal oxidative damage in Alzheimer's disease
/
|
89 |
Acetylcholinesterase in Alzheimer's disease
/
|
90 |
Possible causes of Alzheimer's disease: Amyloid fragments, free radicals, and calcium homeostasis
/
|
91 |
Neurotransmitters and C.N.S. disease dementia
/
|
92 |
Cognitive enhancement therapy for Alzheimer's disease The way forward
/
|
93 |
Acetylcholinesterase inhibition by territrem B derivatives
/
|
94 |
The prevalence of dementia: A quantitative integration of the literature
/
|
95 |
Neuroprotective therapy for Parkinson's disease.
/
|
96 |
Metal ion-catalyzed oxidation of proteins: biochemical mechanisms and biological consequences
/
|
97 |
Oxy-radicals and cancer
/
|
98 |
Oxidative stress: free radical production in neural degeneration
/
|
99 |
Oxidative damage to DNA in diabetes mellitus
/
|
100 |
Neuroprotective effects of the antioxidant LY231617 and NO synthase inhibitors in global cerebral ischaemia
/
|
101 |
Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: Antinociceptive and cardiovascular effects
/
|
102 |
Qualitative and quantitative evaluation of anthraquinone derivaties in Indian rhubarb
/
|
103 |
Monoamine oxidase B in brains from patients with Alzheimer's disease: A biochemical and autoradiographical study
/
|
104 |
The molecular pharmacology of L-deprenyl
/
|
105 |
Purification and properties of human brain mitochondrial monoamine oxidase
/
|
106 |
Pharmacological treatment of cognitive deficits in Azheimer's disease
/
|
107 |
Alzheimer's disease: lesions and their progression
/
|
108 |
Cholinesterase in cerebrosponal fluid. A longitudinal study in Alzheimer disease
/
|
109 |
Alzheimer's disease; A disorder of cortical cholinergic innervation
/
|
110 |
MPTP mechanism of neurotoxicity and their implications for Parkinson's disease
/
|
111 |
Chronic parkinsonism in human due to a product of meperidine analog synthesis
/
|
112 |
The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine in the monkey and man
/
|
113 |
Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase
/
|
114 |
An acetylcholinesterase inhibitor isolated from Corydalis Tuber and its mode of action
/
|
115 |
Intraneuronal generation of a pyridinium metabolic may cause drug-induced parkinsonism
/
|
116 |
Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice
/
|
117 |
/
|
118 |
MPP+ and MPDP+ induced oxygen radical formation with mitochondrial enzymes
/
|
119 |
MPTP-induced oxidative stress and neurotoxicity are age-dependent: evidence from measures of reactive oxygen species dopamine levels
/
|
120 |
Oxidative stress induced by MPTP and MPP+: selective vulnerability of cultured astrocytes
/
|
121 |
Substrate and inhibitor- related characteristics of human platelet monoamine oxidase
/
|
122 |
The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines
/
|
123 |
Effect of MPTP and L-Deprenyl on antioxidants enzymes and lipid peroxidation level in mouse brain
/
|
124 |
Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain
/
|
125 |
Inhibition of mitochondrial NADH dehydrogenase by pyridine derivaties and its possible relation to experimental and idophathic Parkinsonism
/
|
126 |
Organic hydroperoxide-induced lipid peroxidation and cell death in isolated hepatocytes
/
|